DrugInfo seminar: Stepping out of the SHADE. The use of ehealth approaches in the management of co-morbid depression and alcohol/other drug use programs

Uploaded on

Frances Kay Lambkin. DrugInfo seminar: Information and communication technology. 22 August 2011 …

Frances Kay Lambkin. DrugInfo seminar: Information and communication technology. 22 August 2011

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads


Total Views
On Slideshare
From Embeds
Number of Embeds



Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

    No notes for slide
  • For all of the advantages of the Australian Healthcare system, like systems in other developed countries, our health system is under increasing pressure due to a shortage of trained healthcare professionals, suboptimal distribution of services and the increasing demand for care.As a result, our healthcare system is exposed to delays in accessing information and services.This leads to high levels of frustration amongst healthcare providers and clients - particularly disadvantaged groups, including those who are experiencing mental health disorders)This situation is compounded dramatically by the occurrence of comorbidity.
  • Australia was one of the first nations to recognise the potential and benefits of e-health, leading to a number of initiatives in the 1990s aimed at better integrating technology into practice.E-health approaches have been recommended in the newly released Guidelines on the management of co-occurring alcohol and other drug and mental health conditions (led by Kath Mills) and on the NSW Health Professional Practice Guidelines for Psychosocial Interventions in Drug and Alcohol Services.
  • All participants made significant improvements in their depression relative to baselineTherapist reduction = 18 points at 36/mthrel to baselineComputer = 14 pointsPCT = 11 pointsTrend towards the SHADE participants reporting significantly greater reductions in depression at 3-months (14-points) relative to the other treatment conditions (8-9 points)
  • This represents only those people (62%) who met criteria for hazardous alcohol use at baseline.Again, all participants made significant reductions in alcohol consumption relative to baseline. This reduction was greatest for the SHADE participants, although their baseline level of consumption was higher (although not significantly higher) to begin with.Relative to baseline, cac participants reported a 62% reduction in alcohol use at 3 years, Therapist compared to a 44% reduction for therapist cbt, PCT and in fact an increase of 18% among the pct groupSlight trend towards the SHADE participants reporting greater reductions in alcohol use relative to other conditions (especially at 3 months) – but not statistically significant, and may in fact be due to their high baseline consumption.
  • This represented a 25% reduction in binge drinling frequency for both cac and therapist cbt at 3 years relative to baseline, and a 3% reduction for the pct group
  • Relative to baseline, cac participants reported a 67% reductionin marijuana use at 3 years, compared with 44% in therapist cbt participants and 29% for the pct group.Interesting pattern of reduction over time for both PCT and SHADE – with an increase in cannabis use evident at 6-months relative to baseline.
  • Often, the evidence needed to encourage clinicians to support various e-health programs (SHADE included) and to adopt a proposed technology is not compelling, and in many cases is completely absent.2 dissemination trialsMental Health Service SettingEarly Psychosis Service Rob 10-week ProgramDrug and Alcohol Service SettingCounselling, Cannabis Clinic, MERITTanya Skill Modules
  • The failure to understand and effectively communicate the benefits of e-health has been a major impediment to the implementation of e-health in Australia and many other developed countries. But, with the right tools, sound, informed decisions can be made that are based on evidence and a clear understanding of how value can be created from e-health applications in different care settings.We hope that SHADE can go some way towards improving the current situation, if only for the important area of depression and substance use comorbidity.


  • 1. Stepping out of the SHADEThe use of e-health approaches to the treatment of comorbid depression and alcohol/other drug misuse
    Frances Kay-Lambkin, Amanda Baker,
    Brian Kelly, Terry Lewin, Vaughan Carr
    The SHADE Project
    Centre for Brain and Mental Health Research
    National Drug & Alcohol Research Centre
    University of New South Wales, Australia
  • 2. Depression and substance use comorbidity...
    Comorbidity is important because…
    Increases burden of illness and disability
    Negative mood cited most often as cause of relapse across a range of substances
    mild depression elevates the risk of relapse to drinking three-fold in comparison to people without depressive symptomatology
    Consistent association between suicidality, depression and alcohol use problems
    No clear treatment model
    Difficulties accessing treatment
  • 3. Treating depression and substance use comorbidity
    Reducing the burden of disease involves developing and disseminating efficacious treatments
    Australia: 62% of people with mental illness do not seek any professional help.
    Stigma, economic, geographic disadvantage
    Even more the case with comorbid depression and problematic alcohol/other drug use
    Research sparse
  • 4. Health System Challenges...
    “Increased health care service demands, costs and complexities are already testing the limits of the financial, physical and human resources of the Australian Health System...These challenges will not be solved by doing more of the same, particularly given the limits of available human and financial resources...”
    AIHW (2008)
    AHMAC (2008)
  • 5. The potential of e-health to respond to these challenges...
    E-health = rapidly expanding field of health information and communication technology
    Widespread recognition within health sector that better use of e-health initiatives should play a critical role in improving the Australian healthcare system
    Increasing acceptance for individuals to take a more active role in protecting their health and participating in their own health care
  • 6. The potential of e-health approaches
    Treatment can be accessible at times and in locations that suit clients
    May reduce stigma associated with treatment
    Clients can work at their own pace, tailoring the provision of information and strategies
    May be able to circumvent some of the challenges of treatment access
    Particularly for comorbidity
  • 7. The potential of e-health approaches
    In Australia...
    72% of households in 2009 reported home access to the internet
    In Canada...
    Current drinkers significantly more likely than abstainers to have at home internet access (73% vs 50%)
    Illicit drug users (cannabis and cocaine) report equivalent rates of home internet access to non-users
  • 8. RCTs of E-health interventions for…
    Panic disorder
    Chronic tension/migraine
    Complicated grief
    Eating Disorders
    Alcohol Problems
  • 9. The SHADE Project
    Computerized, clinician assisted, combination CBT/MI for depression and alcohol/other drug use problems
  • 10. The SHADE Project
    Developed in the Hunter (NSW)
    Project run in collaboration with Centre for Rural and Remote Mental Health (rural and urban)
    Target depression (and co-occurring alcohol use, cannabis use problems)
    Use CBT
    Compare face-to-face treatment with computer treatment (SHADE) with supportive treatment (PCT)
    Follow-up people up for 3 years
  • 11. Depression
  • 12. Alcohol use
  • 13. Binge Drinking
  • 14. Cannabis use
  • 15. SHADE...
    Andersson & Carlbring (2009)
    “[SHADE] has the potential to fit in well with existing health-care services...”
    Key challenges in the uptake of e-health in clinical practice:
    Access to technology
    Reluctance of healthcare providers to adopt technology or change their practice without compelling reasons to do so
    Research trials attest to efficacy
    Lack of evidence from service-based dissemination trials
    Lack of understanding about the potential for e-health systems to augment health care
    DoHA-funded consultation
    Most common response by community was confusion (“online AA?”, “like MMN or something?”, “what, talking to someone online...?”)
  • 16. So, what’s the upshot for e-health?
    ? Enhanced adherence to best (or evidence-based) practice
    ? Empowering clients to better manage their own health
    Can be applied to the complexities of comorbid depression and alcohol/other drug use
    ? Reduced time and cost addressing comorbidity
    Use of e-health initiatives may be a question of costs, client preference and provider preference
  • 17. Acknowledgements
    Chief Investigators
    Frances Kay-Lambkin
    Amanda Baker
    Brian Kelly
    Terry Lewin
    Vaughan Carr
    Terry Lewin
    Centre for Brain & Mental Health Research
    Follow-up Interviewers
    • Madeleine DeVille
    • 30. Lisa Phillips
    • 31. Veronica Clipsham
    Address for correspondence: Frances.KayLambkin@newcastle.edu.au